STOCK TITAN

Privia Health Group, Inc. - PRVA STOCK NEWS

Welcome to our dedicated page for Privia Health Group news (Ticker: PRVA), a resource for investors and traders seeking the latest updates and insights on Privia Health Group stock.

Privia Health Group, Inc. (symbol: PRVA) is a leading technology-driven national physician enablement company. The organization collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering high-value care both in-person and through virtual platforms. Privia Health focuses on transforming healthcare from a 'sick care' model to a 'well care' model by using innovative technologies and scalable operations.

The company's recent achievements include a significant partnership with Navina, an AI-powered primary care platform. This collaboration aims to equip Privia Health's extensive network of over 3,800 providers and more than 1,000 practice locations by integrating advanced AI technology to improve workflows, patient care, and value-based initiatives. With the help of Navina's clinical intelligence, physicians can better assess patients' health, make informed clinical decisions, and reduce administrative burdens.

Privia Health is recognized for its end-to-end, cloud-based technology platform that reduces unnecessary healthcare costs and achieves better outcomes for patients and providers. The platform is led by top industry talent and exceptional physician leadership, ensuring high-quality healthcare experiences. The company's financial condition remains strong, with net cash provided by operating activities significantly increased to $80.8 million in 2023, a 71.2% rise from the previous year.

The company's culture is defined by passion, curiosity, and a commitment to making a tangible difference in healthcare. Privia Health looks for individuals who are resourceful, hardworking, and driven to challenge the status quo. This ethos is reflected in the company's comprehensive approach to healthcare, striving to create positive, long-lasting impacts on the communities it serves.

For more information, visit priviahealth.com.

Rhea-AI Summary

ARLINGTON, Va., Jan. 31, 2022 - Privia Health Group, Inc. (Nasdaq: PRVA) will release its fourth quarter and full year financial results for 2021 on March 25, 2022, before the market opens. The press release will be available at ir.priviahealth.com by 7:00 AM ET. Following this, the management will hold a conference call at 8:00 AM ET to discuss the results and future outlook. Interested parties can access the call via a webcast or by phone. The recording will be available for replay shortly after the call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.36%
Tags
conferences
-
Rhea-AI Summary

Privia Health Group, Inc. (Nasdaq: PRVA) has launched three new Accountable Care Organizations (ACOs) in Maryland, Florida, and Tennessee, bringing the total to seven ACOs in its portfolio. Effective January 1, 2022, the Privia Quality Network now includes over 1,900 independent providers serving 168,000+ Medicare beneficiaries. Four ACOs have transitioned to the MSSP Enhanced Track, which entails significant financial risks. In 2020, Privia achieved $86.5 million in shared savings through MSSP, with total savings exceeding $576 million since 2014.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.05%
Tags
none
-
Rhea-AI Summary

Privia Health Group, Inc. (Nasdaq: PRVA) has appointed Jeffrey S. Sherman as Executive Vice President and Chief Financial Officer, effective immediately. Sherman, who brings significant financial and healthcare experience from previous roles, will oversee finance and accounting activities. Privia Health CEO Shawn Morris emphasized that Sherman’s background will support the company’s growth and long-term value creation. Sherman succeeds David Mountcastle, who is leaving the company after a successful tenure. Privia Health focuses on optimizing physician practices and enhancing patient experiences.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.45%
Tags
none
Rhea-AI Summary

Privia Health Group, Inc. (Nasdaq: PRVA) has announced new capitated arrangements with HealthFirst Health Plan and Humana for its Accountable Care Organizations (ACOs) in Florida and the Mid-Atlantic region. Effective January 1, 2022, these agreements will provide healthcare services to approximately 23,000 Medicare Advantage beneficiaries. The company expects to generate $230 million in practice collections and GAAP revenue from these contracts in 2022, marking a shift from fee-for-service to care management fees for enhanced healthcare services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.08%
Tags
none
-
Rhea-AI Summary

ARLINGTON, Va., Jan. 04, 2022 – Privia Health Group, Inc. (Nasdaq: PRVA) will participate in the 40th Annual J.P. Morgan Healthcare Conference. The management team is scheduled to present a business overview during a virtual fireside chat on January 10, 2022, at 3:00 PM ET. A webcast, replay, and accompanying slide presentation will be available on their investor relations website.

Privia Health is a technology-driven physician enablement company that collaborates with medical groups and health systems to optimize practices, improve patient experiences, and enhance healthcare quality.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.78%
Tags
conferences
-
Rhea-AI Summary

Privia Health Group, Inc. (Nasdaq: PRVA) has priced its public offering of 6,000,000 shares of common stock at $29.00 per share. The offering, initiated by selling stockholders, includes a 30-day option for underwriters to purchase an additional 900,000 shares. The company will not receive any proceeds from this secondary offering, which is set to close on November 23, 2021. The offering is managed by leading financial institutions including Goldman Sachs and J.P. Morgan. Forward-looking statements highlight potential uncertainties regarding the completion of the offering.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.69%
Tags
none
Rhea-AI Summary

Privia Health Group, Inc. (Nasdaq: PRVA) announced a public offering of 6,000,000 shares of common stock by certain selling stockholders, with a 30-day option for underwriters to purchase an additional 900,000 shares. The company will not receive any proceeds from this offering, as costs will be borne by the selling stockholders. Goldman Sachs & Co. LLC and J.P. Morgan are leading the offering. A registration statement has been filed but is not yet effective, and the offering is subject to numerous conditions outside Privia's control.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Privia Health Group, Inc. (PRVA) announced robust third-quarter results with total revenue reaching $251.5 million, a 21.4% increase year-over-year. However, the company reported a net loss of $9.1 million, or $0.09 per share, compared to a profit of $16.7 million in the same period last year. Practice collections rose to $401.5 million, and adjusted EBITDA grew by 51.9% to $13.9 million. The firm entered the California and West Texas markets, raising its full-year 2021 guidance across multiple metrics, signaling strong growth potential ahead.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.31%
Tags
-
Rhea-AI Summary

Privia Health Group, Inc. (Nasdaq: PRVA), a national physician enablement company, announced its participation in three key investor conferences. The events are scheduled for November 10 at the Credit Suisse Healthcare Conference, November 18 at the Canaccord Genuity Digital Health & Services Forum, and December 1 at the Piper Sandler Healthcare Conference. Webcasts and slide presentations will be accessible via the company's investor relations website. Privia Health focuses on enhancing physician practices and patient experiences through advanced technology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.51%
Tags
conferences
Rhea-AI Summary

Privia Health Group, Inc. (PRVA) is expanding its national provider network by collaborating with over 430 new providers in California and Texas. This includes partnerships with BASS Medical Group in California and Abilene Diagnostic Clinic in West Texas. These ventures aim to enhance patient care and support healthcare providers in their transition to value-based care. The company plans to update its full-year 2021 guidance following its third-quarter financial results on November 8, reflecting the anticipated impact of these expansions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.01%
Tags
none

FAQ

What is the current stock price of Privia Health Group (PRVA)?

The current stock price of Privia Health Group (PRVA) is $20.07 as of December 20, 2024.

What is the market cap of Privia Health Group (PRVA)?

The market cap of Privia Health Group (PRVA) is approximately 2.4B.

What is Privia Health Group, Inc.?

Privia Health Group, Inc. is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices and improve patient experiences.

What recent partnership has Privia Health announced?

Privia Health recently announced a partnership with Navina, an AI-powered primary care platform, to enhance workflows, patient care, and value-based initiatives.

How many providers are part of Privia Health's network?

Privia Health has over 3,800 providers and more than 1,000 practice locations across its network.

What is the financial performance of Privia Health in 2023?

Privia Health reported net cash provided by operating activities of $80.8 million for the year ended December 31, 2023, marking a 71.2% increase from the prior year.

What is the core business model of Privia Health?

Privia Health's core business model focuses on transforming healthcare from a 'sick care' model to a 'well care' model by employing advanced technology and scalable operations.

What type of care does Privia Health provide?

Privia Health provides both in-person and virtual care settings, aiming to deliver high-value healthcare experiences for patients and providers.

What makes Privia Health's technology platform unique?

Privia Health's technology platform is end-to-end and cloud-based, designed to reduce unnecessary healthcare costs, improve patient outcomes, and enhance the well-being of providers.

What are the company's core values?

Privia Health values passion, curiosity, resourcefulness, hard work, and a commitment to challenging the status quo to make a tangible difference in healthcare.

How does Privia Health reward doctors?

Privia Health rewards doctors for delivering high-value care and improving patient experiences.

Where can I find more information about Privia Health?

For more information, visit Privia Health's website at priviahealth.com.

Privia Health Group, Inc.

Nasdaq:PRVA

PRVA Rankings

PRVA Stock Data

2.45B
107.29M
10.49%
103.28%
4.71%
Health Information Services
Services-health Services
Link
United States of America
ARLINGTON